Fifth Third Bancorp’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,314
Closed -$323K 2793
2022
Q3
$323K Buy
1,314
+372
+39% +$100K ﹤0.01% 812
2022
Q2
$233K Buy
942
+30
+3% +$8.1K ﹤0.01% 907
2022
Q1
$302K Sell
912
-1,727
-65% -$532K ﹤0.01% 869
2021
Q4
$948K Buy
2,639
+2,145
+434% +$725K ﹤0.01% 587
2021
Q3
$161K Buy
494
+93
+23% +$31.5K ﹤0.01% 1041
2021
Q2
$125K Buy
401
+67
+20% +$20.6K ﹤0.01% 1114
2021
Q1
$106K Sell
334
-298
-47% -$95.4K ﹤0.01% 1135
2020
Q4
$205K Buy
632
+56
+10% +$15.5K ﹤0.01% 924
2020
Q3
$160K Buy
576
+36
+7% +$10.4K ﹤0.01% 948
2020
Q2
$130K Sell
540
-10
-2% -$2.01K ﹤0.01% 1008
2020
Q1
$80K Buy
550
+61
+12% +$10.1K ﹤0.01% 1125
2019
Q4
$83K Buy
489
+78
+19% +$14.5K ﹤0.01% 1236
2019
Q3
$73K Sell
411
-1
-0.2% -$216 ﹤0.01% 1241
2019
Q2
$107K Buy
412
+62
+18% +$16.4K ﹤0.01% 1109
2019
Q1
$100K Buy
350
+295
+536% +$98K ﹤0.01% 1066
2018
Q4
$18K Buy
55
+38
+224% +$13.2K ﹤0.01% 1630
2018
Q3
$8K Buy
17
+14
+467% +$5.52K ﹤0.01% 1897
2018
Q2
$1K Buy
+3
New +$1.09K ﹤0.01% 2248
2018
Q1
Sell
-5
Closed -$1K 2434
2017
Q4
$1K Buy
+5
New +$934 ﹤0.01% 2237
2016
Q1
Sell
-109
Closed -$10K 2744
2015
Q4
$10K Buy
109
+2
+2% +$170 ﹤0.01% 1959
2015
Q3
$10K Sell
107
-36
-25% -$3.17K ﹤0.01% 2031
2015
Q2
$9K Buy
143
+77
+117% +$5.12K ﹤0.01% 2139
2015
Q1
$5K Buy
+66
New +$3.58K ﹤0.01% 2242

Other funds holding ABMD

Fifth Third Bancorp's ABMD Position: Q4 2022 in Review

Fifth Third Bancorp sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,314 shares — an estimated $323K sold.

Fifth Third Bancorp first reported a position in ABMD in Q1 2015 and held it in 23 quarters. The position peaked at $948K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Fifth Third Bancorp reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,314 Abiomed Inc shares in Q4 2022, an estimated $323K.
  • Fifth Third Bancorp first reported a position in Abiomed Inc in Q1 2015 and held it in 23 quarters.
  • Fifth Third Bancorp's Abiomed Inc position peaked at $948K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Fifth Third Bancorp's 13F filing for Q4 2022, filed 25 Jan 2023.